Sökning: onr:"swepub:oai:DiVA.org:uu-406063" > Mycoplasma pneumoni...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 08006naa a2200889 4500 | |
001 | oai:DiVA.org:uu-406063 | |
003 | SwePub | |
008 | 200304s2020 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:142763266 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4060632 URI |
024 | 7 | a https://doi.org/10.2807/1560-7917.ES.2020.25.2.19001122 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1427632662 URI |
040 | a (SwePub)uud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Beeton, Michael L.u Cardiff Metropolitan Univ, Dept Biomed Sci, Cardiff, S Glam, Wales4 aut |
245 | 1 0 | a Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016 |
264 | 1 | b EUR CENTRE DIS PREVENTION & CONTROL,c 2020 |
338 | a electronic2 rdacarrier | |
520 | a Background: Mycoplasma pneumoniae is a leading cause of community-acquired pneumonia, with large epidemics previously described to occur every 4 to 7 years.Aim: To better understand the diagnostic methods used to detect M. pneumoniae; to better understand M. pneumoniae testing and surveillance in use; to identify epidemics; to determine detection number per age group, age demographics for positive detections, concurrence of epidemics and annual peaks across geographical areas; and to determine the effect of geographical location on the timing of epidemics.Methods: A questionnaire was sent in May 2016 to Mycoplasma experts with national or regional responsibility within the ESCMID Study Group for Mycoplasma and Chlamydia Infections in 17 countries across Europe and Israel, retrospectively requesting details on M. pneumoniae-positive samples from January 2011 to April 2016. The Moving Epidemic Method was used to determine epidemic periods and effect of country latitude across the countries for the five periods under investigation.Results: Representatives from 12 countries provided data on M. pneumoniae infections, accounting for 95,666 positive samples. Two laboratories initiated routine macrolide resistance testing since 2013. Between 2011 and 2016, three epidemics were identified: 2011/12, 2014/15 and 2015/16. The distribution of patient ages for M. pneumoniae-positive samples showed three patterns. During epidemic years, an association between country latitude and calendar week when epidemic periods began was noted.Conclusions: An association between epidemics and latitude was observed. Differences were noted in the age distribution of positive cases and detection methods used and practice. A lack of macrolide resistance monitoring was noted. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Infektionsmedicin0 (SwePub)302092 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Infectious Medicine0 (SwePub)302092 hsv//eng |
700 | 1 | a Zhang, Xu-Shengu Publ Hlth England, London, England4 aut |
700 | 1 | a Uldum, Soren A.u Statens Serum Inst, Dept Bacteria Parasites & Fungi, Copenhagen, Denmark4 aut |
700 | 1 | a Bebear, Cecileu Univ Bordeaux, Mycoplasmal & Chlamydia Infect Humans, USC EA 3671, Bordeaux, France4 aut |
700 | 1 | a Dumke, Rogeru Tech Univ Dresden, Dresden, Germany4 aut |
700 | 1 | a Gullsby, Karolinau Uppsala universitet,Centrum för klinisk forskning, Gävleborg4 aut0 (Swepub:uu)kagul102 |
700 | 1 | a Ieven, Margaretau Antwerp Univ Hosp Edegem, Edegem, Belgium4 aut |
700 | 1 | a Loens, Katherineu Antwerp Univ Hosp Edegem, Edegem, Belgium4 aut |
700 | 1 | a Nir-Paz, Ranu Hadassah Hebrew Univ, Med Ctr, Dept Clin Microbiol & Infect Dis, Jerusalem, Israel4 aut |
700 | 1 | a Pereyre, Sabineu Univ Bordeaux, Mycoplasmal & Chlamydia Infect Humans, USC EA 3671, Bordeaux, France4 aut |
700 | 1 | a Spiller, O. Bradu Cardiff Univ, Sch Med, Dept Med Microbiol, Div Infect & Immun, Cardiff, S Glam, Wales4 aut |
700 | 1 | a Chalker, Victoria J.u Publ Hlth England, London, England4 aut |
700 | 1 | a Bossuyt, Nathalieu Sciensano, Serv Epidemiol Infect Dis, Brussels, Belgium4 aut |
700 | 1 | a Lagrou, Katrienu Univ Hosp Leuven, Natl Reference Ctr Resp Pathogens, Leuven, Belgium4 aut |
700 | 1 | a Mitis, Georgeu Nicosia Gen Hosp, Dept Immunol, Nicosia, Cyprus4 aut |
700 | 1 | a Koliou, Mariau Archbishop Makarios III Hosp, Dept Paediat, Nicosia, Cyprus4 aut |
700 | 1 | a Havlickova, Martinau Natl Inst Publ Hlth, Prague, Czech Republic4 aut |
700 | 1 | a Kyncl, Janu Natl Inst Publ Hlth, Prague, Czech Republic4 aut |
700 | 1 | a Emborg, Hanne-Dortheu Statens Serum Inst, Copenhagen, Denmark4 aut |
700 | 1 | a Voldstedlund, Marianneu Statens Serum Inst, Copenhagen, Denmark4 aut |
700 | 1 | a MacKenzie, Colin Raeu Heinrich Heine Univ, Inst Med Microbiol & Hosp Hyg, Dusseldorf, Germany4 aut |
700 | 1 | a Maltezou, Helena C.u Natl Publ Hlth Org, Athens, Greece4 aut |
700 | 1 | a Georgakopoulou, Theanou Natl Publ Hlth Org, Athens, Greece4 aut |
700 | 1 | a Petridou, Evangelinau Aghia Sophia Children Hosp, Athens, Greece4 aut |
700 | 1 | a Banou, Kirkirau Aghia Sophia Children Hosp, Athens, Greece4 aut |
700 | 1 | a Balla, Eszteru Natl Publ Hlth Ctr, Dept Reference Labs, Budapest, Hungary4 aut |
700 | 1 | a Connell, Jeffu Univ Coll Dublin, Natl Virus Reference Lab, Dublin, Ireland4 aut |
700 | 1 | a Yandle, Zoeu Univ Coll Dublin, Natl Virus Reference Lab, Dublin, Ireland4 aut |
700 | 1 | a Moran, Joanneu Univ Coll Dublin, Natl Virus Reference Lab, Dublin, Ireland4 aut |
700 | 1 | a Burns, Karenu Hlth Protect Surveillance Ctr, Dublin, Ireland4 aut |
700 | 1 | a Michael-Gayego, Ayeletu Hadassah Hebrew Univ, Med Ctr, Dept Clin Microbiol & Infect Dis, Jerusalem, Israel4 aut |
700 | 1 | a Moses, Allon E.u Hadassah Hebrew Univ, Med Ctr, Dept Clin Microbiol & Infect Dis, Jerusalem, Israel4 aut |
700 | 1 | a Fenech, Tanya Melillou Minist Hlth, Valletta, Malta4 aut |
700 | 1 | a Anestad, Gabrielu Norwegian Inst Publ Hlth, Oslo, Norway4 aut |
700 | 1 | a Blystad, Hansu Norwegian Inst Publ Hlth, Oslo, Norway4 aut |
700 | 1 | a Vestrheim, Didrik F.u Norwegian Inst Publ Hlth, Oslo, Norway4 aut |
700 | 1 | a Froes, Filipeu Hosp Pulido Valente, Lisbon, Portugal;Gen Directorate Hlth Consultant Pneumol, Lisbon, Portugal4 aut |
700 | 1 | a Kese, Darjau Univ Ljubljana, Fac Med, Ljubljana, Slovenia;Inst Microbiol & Immunol, Ljubljana, Slovenia4 aut |
700 | 1 | a Socan, Majau Natl Inst Publ Hlth, Ljubljana, Slovenia4 aut |
700 | 1 | a Cano Portero, Rosau Inst Salud Carlos III, CIBERESP, Natl Ctr Epidemiol, Madrid, Spain4 aut |
700 | 1 | a Santos Sanz, Sarau Minist Hlth Social Affairs & Equal, Directorate Gen Publ Hlth, Coordinat Alerts & Publ Hlth Emergencies, Madrid, Spain4 aut |
700 | 1 | a Suarez Rodriguez, Bertau Minist Hlth Social Affairs & Equal, Directorate Gen Publ Hlth, Coordinat Alerts & Publ Hlth Emergencies, Madrid, Spain4 aut |
700 | 1 | a Ternhag, Andersu Karolinska Institutet4 aut |
700 | 1 | a Giske, Christianu Karolinska Institutet4 aut |
700 | 1 | a Wisell, Karin Tegmarku Publ Hlth Agcy Sweden, Stockholm, Sweden4 aut |
700 | 1 | a Marques, Diogo Pereirau Hlth Protect Scotland, Glasgow, Lanark, Scotland4 aut |
700 | 1 | a Reynolds, Arleneu Hlth Protect Scotland, Glasgow, Lanark, Scotland4 aut |
700 | 1 | a McMenamin, Jimu Hlth Protect Scotland, Glasgow, Lanark, Scotland4 aut |
710 | 2 | a Cardiff Metropolitan Univ, Dept Biomed Sci, Cardiff, S Glam, Walesb Publ Hlth England, London, England4 org |
773 | 0 | t Eurosurveillanced : EUR CENTRE DIS PREVENTION & CONTROLg 25:2, s. 39-51q 25:2<39-51x 1025-496Xx 1560-7917 |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1411862/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-406063 |
856 | 4 8 | u https://doi.org/10.2807/1560-7917.ES.2020.25.2.1900112 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:142763266 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.